This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US DOJ, states call Google's remedies proposal 'anemic' in pre-trial brief

( April 17, 2025, 00:36 GMT | Official Statement) -- MLex Summary: Google's proposed final judgment "falls woefully short of meeting the objectives" that the US Court of Appeals for the District of Columbia Circuit identified in US v Microsoft, the US Department of Justice and a multi-state coalition told a federal judge in Washington, DC. In a pre-trial brief, the DOJ and states argued that their proposal does satisfy Microsoft’s objectives. "The proposed remedies — developed after receiving input from market participants as well as fact and expert discovery— prohibit the anticompetitive distribution agreements and payments," the plaintiffs wrote. "They prohibit similar conduct and likely means of future monopolization (e.g., self-preferencing, retaliation). And they aim to reduce barriers to entry, thereby curbing Google’s monopoly power and denying Google the fruits of its statutory violations." Pre-trial brief is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login